← All companies
PBSV
Pharma-Bio Serv, Inc.
$0.42
+0.00 0.00%
Key statistics
from XBRL data in SEC filingsMarket cap
$9.62M
Revenue (TTM)
$9.11M
Net income (TTM)
$61.5K
EPS (TTM)
$0.00
P/E ratio
140.0
Dividend yield
17.86%
Free cash flow
-$246K
Cash
$1.79M
Total assets
$11.5M
Gross margin
32.4%
52-week range
$0.42 – $1.36
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Results of operations (earnings release)
Jun 15, 2026
10-Q
Quarter ended 2026-04-30
Jun 15, 2026
8-K
Shareholder vote results
May 15, 2026
8-K
Results of operations (earnings release)
Mar 17, 2026
10-Q
Quarter ended 2026-01-31
Mar 17, 2026
10-K/A
Fiscal year ended 2025-10-31
Feb 27, 2026
8-K
Results of operations (earnings release)
Jan 29, 2026
10-K
Fiscal year ended 2025-10-31
Jan 29, 2026
8-K
Results of operations (earnings release)
Sep 15, 2025
10-Q
Quarter ended 2025-07-31
Sep 15, 2025
8-K
Results of operations (earnings release)
Jun 16, 2025
10-Q
Quarter ended 2025-04-30
Jun 16, 2025
8-K
Shareholder vote results
May 16, 2025
8-K
Results of operations (earnings release)
Mar 17, 2025
10-Q
Quarter ended 2025-01-31
Mar 17, 2025
10-K/A
Fiscal year ended 2024-10-31
Feb 28, 2025
8-K
Results of operations (earnings release)
Jan 29, 2025
8-K
Other events
Jan 29, 2025
10-K
Fiscal year ended 2024-10-31
Jan 29, 2025
8-K
Results of operations (earnings release)
Sep 16, 2024
10-Q
Quarter ended 2024-07-31
Sep 16, 2024
8-K
Results of operations (earnings release)
Jun 14, 2024
10-Q
Quarter ended 2024-04-30
Jun 14, 2024
8-K
Director or officer change; Shareholder vote results
May 2, 2024
8-K
Results of operations (earnings release)
Mar 18, 2024
10-Q
Quarter ended 2024-01-31
Mar 18, 2024
10-K/A
Fiscal year ended 2023-10-31
Feb 28, 2024
8-K
Results of operations (earnings release)
Jan 30, 2024
10-K
Fiscal year ended 2023-10-31
Jan 29, 2024
8-K
Other events
Dec 21, 2023
8-K
Results of operations (earnings release)
Sep 14, 2023
10-Q
Quarter ended 2023-07-31
Sep 14, 2023
8-K
Results of operations (earnings release)
Jun 14, 2023
10-Q
Quarter ended 2023-04-30
Jun 14, 2023
8-K
Shareholder vote results
May 31, 2023
8-K
Results of operations (earnings release)
Mar 17, 2023
10-Q
Quarter ended 2023-01-31
Mar 17, 2023
8-K
Other events
Mar 1, 2023
10-K/A
Fiscal year ended 2022-10-31
Feb 28, 2023
8-K
Amended charter or bylaws
Feb 9, 2023